FEDERAL COURT OF AUSTRALIA
Cytec Industries Inc. v Nalco Company (No 4) [2024] FCA 1318
Appeal from: Cytec Industries Inc. v Nalco Company [2019] APO 2 File number(s): NSD 130 of 2019 Judgment of: BURLEY J Date of judgment: 15 November 2024 Catchwords: PATENTS – application to amend patent application following determination of appeal under s 60(4) of the Patents Act 1990 (Cth) – whether proposed amendments allowable under s 102 of the Patents Act – application refused
PATENTS – whether proposed amendments overcome deficiencies identified on appeal from opposition proceedings – lack of support – lack of clear and complete description
PATENTS – claim construction – whether claims include within their scope a reaction product mixture containing only the named small molecules
Legislation: Federal Court of Australia Act 1976 (Cth) ss 37M and 37N
Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth)
Patents Act1990 (Cth)ss 40(2)(a), 40(2)(aa), 40(3), 59, 60(4), 102(1), 102(2), 105(1A), 105(4) and 112A
Cases cited: Autodesk Inc v Dyason (No 2) [1993] HCA 6; (1993) 176 CLR 300
Commissioner of Patents v Rokt Pte Ltd [2020] FCAFC 86; (2020) 277 FCR 267
Cytec Industries Inc. v Nalco Company [2018] APO 4.
Cytec Industries Inc. v Nalco Company [2019] APO 2
Cytec Industries Inc. v Nalco Company [2019] FCA 1800
Cytec Industries Inc. v Nalco Company [2021] FCA 970
Davies v Lazer Safe Pty Ltd [2019] FCAFC 65
Genetics Institute Inc v Kirin-Amgen Inc [1999] FCA 742; (1999) 92 FCR 106
Les Laboratoires Servier v Apotex Pty Ltd (2016) 247 FCR 61; [2016] FCAFC 27
Meat & Livestock Australia Limited v Cargill, Inc (No 2) (2019) 139 IPR 147; [2019] FCA 33
Neurim Pharmaceuticals (1991) Ltd v Generic Partners Pty Ltd (No 2) (2019) 139 IPR 424; [2019] FCA 154
Nichia Corporation v Arrow Electronics Australia Pty Ltd [2019] FCAFC 2; (2019) 175 IPR 187
Nutrasweet Australia Pty Ltd v Ajinomoto Co Inc (No 3) [2007] FCA 966; (2007) 73 IPR 282
Prince Alfred College Inc v ADC [2016] HCA 37; (2016) 258 CLR 134
Repipe Pty Ltd v Commissioner of Patents (No 3) [2021] FCA 31
ToolGen Incorporated v Fisher (No 3) [2024] FCA 539
Welch Perrin & Co Pty Ltd v Worrel [1961] HCA 91; (1961) 106 CLR 588
Division: General Division Registry: New South Wales National Practice Area: Intellectual Property Sub-area: Patents and associated Statutes Number of paragraphs: 111 Date of hearing: 8 June 2023; 15 June 2023; 14 December 2023 Counsel for the Appellant / Cross-Respondent: Mr C Dimitriadis SC, Mr BA Mee Solicitor for the Appellant / Cross-Respondent: Allens Counsel for the Respondent / Cross-Appellant: Mr JS Cooke SC, Ms M Evetts, Ms S Yates Solicitor for the Respondent / Cross-Appellant: Spruson & Ferguson Lawyers Pty Limited ORDERS
NSD 130 of 2019 BETWEEN: CYTEC INDUSTRIES INC.
Appellant
AND: NALCO COMPANY
Respondent
AND BETWEEN: NALCO COMPANY
Cross-Appellant
AND: CYTEC INDUSTRIES INC.
Cross-Respondent
ORDER MADE BY:
BURLEY J
DATE OF…
Keep reading for free
Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company (No 4) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2024] FCA 1318
- Decision Date
CaseChat Overview and Summary
The court considered whether the proposed amendments adequately addressed the deficiencies in support and clarity of the description, which were central issues in the earlier appeal. The court found that the amendments did not sufficiently alter the meaning of the claims to avoid the issues of lack of support and lack of a clear and complete description. Specifically, the court held that the amendments failed to change the interpretation of the word "comprising" or the phrase "within a product mixture," and did not address the core issue that the technical contribution of the specification was not directed to isolating specific small molecules. The court also rejected Nalco's arguments concerning the hydrolysis construction of the claims.
Ultimately, the court refused Nalco's application to amend the patent, finding that the proposed amendments were not allowable under the Patents Act and did not sufficiently address the deficiencies identified in the earlier appeal. The court ordered the parties to confer and submit short minutes of order within 14 days, reflecting the terms of the judgment, and to outline any areas of disagreement if they were unable to reach an agreement.
Orders
Orders of the court
1. The parties confer and supply to the chambers of Justice Burley, within 14 days, short minutes of order giving effect to these reasons.
2. Insofar as the parties are unable to agree to the terms of the short minutes of order referred to in order 1, the areas of disagreement should be set out in mark-up.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Nor do I consider that the passage on page 34 of the specification (quoted at [82] above) provides a basis for reading down the language of amended claim 1. The examples are expressed to be given without limitation to the scope of the invention. Whilst the specification does make a distinction between hydrolysed and non-hydrolysed product mixtures, the language of the claims does not. That this was a clear choice on the part of the drafter is further apparent from the language of the current claim set, which in claim 16 provides for a “method according to claim 1, wherein the composition is hydrolyzed prior to being added to the Bayer process”. 5. CONSIDERATION OF THE GROUNDS OF OPPOSITION I have found above that the small molecule construction issue be determined in favour of Cytec such that the amended claims include within their scope a composition that includes only the identified small molecules within a product mixture, although a large number of other small molecules and polymers may also be included. I have also found that Nalco’s arguments in relation to the hydrolysis construction issue must be rejected. The finding in relation to the small molecule construction issue has the consequence that Cytec’s ground 4 does not arise, because its lack of clarity point is pleaded on the basis that Nalco’s construction is accepted, which it is not. The finding in relation to the hydrolysis construction issue has the consequence that ground 6A also does not arise, because the lack of best method ground pleaded is based on Nalco’s construction, which I have rejected. The remaining grounds concern the consequences of my findings in relation to the small molecule construction issue. Cytec submits that in light of this construction the amendment application must be determined adversely to Nalco on three separate alternative bases. First, that as a matter of discretion the amendment is futile and ought to be refused (ground 7), second, that the amendment is not allowable because as a result of the amendment the specification would claim matter that extends beyond that disclosed in the complete specification in breach of s 105(4) and s 102(1) (ground 5) and thirdly because as a result of the amendment the specification would not comply with the requirement of s 40(2)(a) that the specification disclose the invention clearly and be supported within the requirements of s 40(3) in breach of s105(4) and s 102(2)(b) (ground 6). For the reasons given below, I accept that each of these grounds applies to defeat the application to amend. 5.1 Lack of support and lack of clear and complete description The construction that I have determined in relation to the small molecule construction issue is one that is materially the same as that which I adopted in the judgment in section 5.2. In short, I concluded that the word “comprising” in current claim 1 is to be given the inclusive meaning defined in the body of the specification, with the consequence that claim 1 includes within its scope a product mixture formed from the reaction of A + GPS + E that consisted entirely of a single type of small molecule. I have reached the same conclusion in section 4.2 above albeit that instead of a single type of small molecule for amended claim 1 there are 13 specified small molecules, for amended claims 2 and 3 there are 14 specified small molecules and for amended claims 4 and 5 there are three such specified small molecules. Indeed, it seems to me that the ineluctable outcome of the reasoning set out in the judgment is that I should reach the same conclusion in relation to the amended claims. The amendments proposed by Nalco do not serve to afford any different meaning to the word “comprising” or the words “within a product mixture” in the context of the amended claims. Nor was there any material difference in the evidence concerning the fact that the technical contribution of the specification was not directed to the ability to isolate given small molecules – whether it be a single small molecule or a group of small molecules.